Artificial intelligence tool to spot sepsis in patients
Part of Infections clinical trials.
This trial is testing a new tool that uses artificial intelligence and biomarkers (substances in your blood) to help doctors recognize sepsis earlier. If you have been diagnosed with sepsis or are suspected of having it, this study may help improve how quickly and accurately it's detected.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 3 months and 45 years old.
- You must have been diagnosed with sepsis, or you must have triggered a sepsis alert and had a blood culture ordered.
- You will need to have blood drawn, either from a new needle stick or from an IV that is already in place.
- You or your legal guardian must be able to speak English or Spanish.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a new tool can help doctors spot sepsis early in children. If your child is under 18, had a blood culture, and received strong antibiotics within the first day in the hospital, they may qualify.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This trial is testing whether certain markers in your blood or other samples can help doctors diagnose sepsis (a severe infection that affects your organs) more quickly. If you join, the study will use samples already collected to look for these markers, which might lead to faster treatment for future patients.
This study tests two new blood tests to see if they can help doctors find sepsis earlier in the emergency department. Sepsis is a serious condition where the body overreacts to an infection, and finding it quickly could lead to faster treatment and better outcomes.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.